![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as ... Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension. Show more
Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update PR Newswire BRIDGEWATER, N.J., Aug. 8, 2024 —ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., Aug. 2, 2024 BRIDGEWATER, N.J., Aug. 2, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.62 | -3.31268175496 | 79.09 | 80.3 | 74.06 | 2344001 | 77.30555136 | CS |
4 | 3.02 | 4.11164057182 | 73.45 | 80.53 | 67.22 | 2244633 | 75.63504969 | CS |
12 | 19.3 | 33.7589644919 | 57.17 | 80.53 | 55.74 | 2570812 | 70.928566 | CS |
26 | 47.88 | 167.471143757 | 28.59 | 80.53 | 21.92 | 2706176 | 52.10749074 | CS |
52 | 54.81 | 253.047091413 | 21.66 | 80.53 | 21.5 | 2151119 | 42.80852085 | CS |
156 | 49.51 | 183.642433234 | 26.96 | 80.53 | 16.04 | 1449567 | 32.12588546 | CS |
260 | 59.66 | 354.90779298 | 16.81 | 80.53 | 12.09 | 1279180 | 30.61237033 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions